Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Erika J Crosby
Assistant Professor in Surgery
Surgery, Surgical Sciences
erika.crosby@duke.edu
203 Research Drive, MSRB1 Box 2606, Durham, NC 27710
MSRB1 Room 288, Durham, NC 27710
Menu
{hide_children: true, active: false, enabled: true}
AT A GLANCE
{hide_children: true, active: false, enabled: true}
Credentials
Education
{hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
{hide_children: true, active: false, enabled: false}
Expertise
{hide_children: false, active: true, enabled: true}
Research
Selected Grants
{hide_children: true, active: false, enabled: true}
Publications
Selected Publications
{hide_children: true, active: false, enabled: false}
Artistic Works / Events
{hide_children: true, active: false, enabled: true}
Teaching
Recent Courses
{hide_children: true, active: false, enabled: true}
Advising & Mentoring
Available to Mentor
Advising & Mentoring
{hide_children: true, active: false, enabled: false}
Recognition
{hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Selected Grants
Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CME
Mentor ·
Awarded by National Institutes of Health ·
2019 - 2029
Targeted vaccination against common resistance genes and neoepitope mutation drivers to treat and prevent endocrine-resistant ER+ Breast Cancer
Research
Co Investigator ·
Awarded by Department of Defense ·
2024 - 2027
Spatial multiomic evaluation of clinical responders with advanced triple negative breast cancer from KEYNOTE-890 to validate a published CXCR3 gene signature
Research
Principal Investigator ·
Awarded by Department of Defense ·
2023 - 2027
The paradox of obesity, tumor progression, and checkpoint inhibition in TNBC
Research
Principal Investigator ·
Awarded by Susan G Komen for the Cure ·
2023 - 2026
A Window-of-Opportunity Trial Using Neoadjuvant Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
Research
Co Investigator ·
Awarded by Marc Lustgarten Pancreatic Cancer Foundation ·
2023 - 2026
More
Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CME
Mentor ·
Awarded by National Institutes of Health ·
2019 - 2029
Targeted vaccination against common resistance genes and neoepitope mutation drivers to treat and prevent endocrine-resistant ER+ Breast Cancer
Research
Co Investigator ·
Awarded by Department of Defense ·
2024 - 2027
Spatial multiomic evaluation of clinical responders with advanced triple negative breast cancer from KEYNOTE-890 to validate a published CXCR3 gene signature
Research
Principal Investigator ·
Awarded by Department of Defense ·
2023 - 2027
The paradox of obesity, tumor progression, and checkpoint inhibition in TNBC
Research
Principal Investigator ·
Awarded by Susan G Komen for the Cure ·
2023 - 2026
A Window-of-Opportunity Trial Using Neoadjuvant Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
Research
Co Investigator ·
Awarded by Marc Lustgarten Pancreatic Cancer Foundation ·
2023 - 2026
Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory
Research
Co Investigator ·
Awarded by Department of Defense ·
2021 - 2025
Defining a CXCR3-associated gene signature as a predictive biomarker and alternate target of immunotherapy across molecular subtypes of breast cancer
Research
Principal Investigator ·
Awarded by National Cancer Institute ·
2022 - 2025
Beyond PD1: An immunotherapeutic strategy to stimulate and enable both T-cell and B-cell responses in immunosuppressive and non-mutated metastatic breast cancer
Research
Postdoctoral Associate ·
Awarded by Department of Defense ·
2020 - 2025
Rapid identification and selection of functional antigen-specific monoclonal antibodies by FcGR-enabled screening on CytoSort Arrays in the CellRaft AIR System
Research
Co Investigator ·
Awarded by Cell Microsystems, Inc. ·
2023 - 2025
Immunotherapeutic Targeting of a Therapy Resistant Oncogenic HER2 Isoform
Research
PI-Fellow ·
Awarded by Susan G. Komen Breast Cancer Foundation ·
2017 - 2020
Less
